Diamond Hill Capital Management Inc. Cuts Stock Position in HCA Healthcare, Inc. $HCA

Diamond Hill Capital Management Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 92.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 46,961 shares of the company’s stock after selling 618,170 shares during the quarter. Diamond Hill Capital Management Inc.’s holdings in HCA Healthcare were worth $21,924,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. National Pension Service lifted its stake in shares of HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after purchasing an additional 17,531 shares during the last quarter. Nordea Investment Management AB raised its holdings in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after buying an additional 108,849 shares during the period. Savant Capital LLC increased its holdings in HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares during the period. Sector Gamma AS increased its holdings in HCA Healthcare by 36.0% during the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after purchasing an additional 2,883 shares during the period. Finally, AlphaQuest LLC increased its holdings in shares of HCA Healthcare by 2,855.2% in the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock valued at $2,557,000 after acquiring an additional 5,796 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft decreased their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. KeyCorp reduced their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Argus reduced their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Leerink Partners reduced their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Barclays decreased their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $515.77.

Get Our Latest Research Report on HCA Healthcare

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Trading Down 1.1%

Shares of HCA Healthcare stock opened at $392.39 on Friday. The business’s fifty day moving average price is $468.01 and its 200 day moving average price is $484.24. The stock has a market capitalization of $87.05 billion, a P/E ratio of 13.49, a PEG ratio of 1.26 and a beta of 1.18. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.